Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. McDonald (Callaghan, Australia), S. Hiles (Callaghan, Australia), K. Godbout (Que´bec City, Canada), E. Harvey (Callaghan, Australia), G. Marks (Glebe, Australia), M. Hew (Melbourne, Australia), M. Peters (Concord, Australia), P. Bardin (Clayton, Australia), P. Reynolds (Adelaide, Australia), J. Upham (Woolloongabba, Australia), M. Baraket (Liverpool, Australia), Z. Bhikoo (Hamilton, New Zealand), J. Bowden (Bedford Park, Australia), B. Brockway (Dunedin, New Zealand), L. Chung (Murdoch, Australia), B. Cochrane (Campbelltown, Australia), G. Foxley (Glebe, Australia), J. Garrett (Auckland, New Zealand), L. Jayaram (Melbourne, Australia), C. Jenkins (Newtown, Australia), C. Katelaris (Campbelltown, Australia), G. Katsoulotos (Sydney, Australia), M. Koh (Singapore, Singapore), V. Kritikos (Glebe, Australia), M. Lambert (Palmerston North, New Zealand), D. Langton (Frankston, Australia), A. Lara Rivero (Sydney, Australia), P. Middleton (Westmead, Australia), A. Nanguzgambo (Palmerston North, New Zealand), N. Radhakrishna (Melbourne, Australia), H. Reddel (Camperdown, Australia), J. Rimmer (Glebe, Australia), A. Southcott (Footscray, Australia), M. Sutherland (Heidelberg, Australia), F. Thien (Box Hill, Australia), P. Wark (Callaghan, Australia), I. Yang (Chermside, Australia), E. Yap (Auckland, New Zealand), P. Gibson (Callaghan, Australia). Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors. 5043

Member's Comments

No comment yet.

Related content which might interest you: Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021 Multi-symptom asthma as an indication of disease severity in epidemiology Source: Eur Respir J 2011; 38: 825-832 Year: 2011 Risk factors for asthma exacerbations: is severity a predictor? Source: Annual Congress 2003 - Burden of asthma Year: 2003 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020 Year: 2021 Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Risk factors responsible for the development of severe asthma in outpatients Source: Eur Respir J 2002; 20: Suppl. 38, 427s Year: 2002 Late Breaking Abstract - Which treatable traits matter?  Prevalence of treatable traits and risk of exacerbation in a random population sample with asthma Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Prevalence of non-pharmacological treatable traits in patients with asthma Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases Year: 2020 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 How can treatable traits be used in severe exacerbations? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Severe asthma among adults: Prevalence and clinical characteristics Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Identifying factors associated with severe asthma exacerbations: a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 626s Year: 2007 Obesity in pediatric asthma: prevalence and impact on severity Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017 Exacerbations in severe persistent asthma - impact of risk factors control Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005